TrialThe British journal of ophthalmology2026

Augmented medial rectus recession versus botulinum toxin therapy for acute acquired comitant esotropia: analysis of outcomes and recurrence predictors.

Yueping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.